Dr. Reddy's Laboratories, Inc. recalls Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx…
FAILED DISSOLUTION SPECIFICATIONS
Read the official notice →- Date
- 2022-08-03
- Country
- United States
- Brand
- Dr. Reddy's Laboratories
- Product
- Lansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs of 10 Tablets Each, Rx Only,…
- Classification
- Class II
- Units
- Nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Dr. Reddy's Laboratories recalls
- 2023-03-01
USDr. Reddy's Laboratories, Inc. recalls Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500 090,…
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.
- 2022-12-07
- US
- 2022-10-12
- US
Dr. Reddy's Laboratories, Inc. recalls Phytonadione Injectable Emulsion USP, 10 mg/mL, 25x 1 mL single dose ampules per carton, Rx only, Distributed by: Dr. Reddy's…
Failed Stability Specifications: Out of specification results reported at 12-month stability testing for aluminum content.
- 2022-05-11
- US
- 2022-04-06
- US
Dr. Reddy's Laboratories, Inc. recalls Lansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's Laboratories Limited,…
Failed Dissolution Specifications; during long term stability testing.
- US
Dr. Reddy's Laboratories, Inc. recalls Atorvstatin Calcium Tablets, USP 80 mg*, 90 Tablets, Rx Only, Mrd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409,…
Failed Impurities/Degradation Specifications: Out of Specification results for related substance.
Other drugs & medical recalls in the United States
- 2022-08-03
- US
SUN PHARMACEUTICAL INDUSTRIES INC recalls Divalproex Sodium Delayed-Release Tablets, USP 500mg, Rx Only, 100 Tablets, Distributed by: Sun Pharmaceutical Industries,…
Failed Dissolution Specifications: Failure occurred during routine stability testing of dissolution test.
- US
The Procter & Gamble Company recalls Crest 3D White Fluoride Anticavity Toothpaste, Advanced Triple Whitening, 0.243% sodium fluoride, Net Wt. 5.6 oz (158 g) a)…
Labeling: Missing label: the product tube was missing a label and contained a different formulation.
- US
Teva Pharmaceuticals USA Inc recalls Testosterone Gel 1% (25mg testosterone/2.5g of gel) 2.5 g per unit dose, Rx Only, 30 unit-dose packets per box. Manufactured by:…
Superpotent Drug: Out of specification assay result was obtained during stability testing.
- US
- 2022-07-27
- US
Stryker Instruments Div. of Stryker Corporation recalls SurgiCount+ System Application, Software Version 2.0.17, Catalog Number 0694-002-090. Used for counting,…
When scanning sponges out after a surgical procedure, an error may allow for a duplicate sponge to be counted without the prompt to make a case note and allowing the case to close. The software update will prevent the…
FDA · DeviceStryker Instruments Div. of Stryker CorporationThe products were distributed to the following US states: KS and ME.Official notice → - US
LumiraDx recalls LumiraDx SARS-CoV-2 Antibody (Ab) Liquid Quality Control
Modification to the LumiraDx SARS-CoV-2 Antibody (Ab) test that was made outside the scope of the approved EUA.
FDA · DeviceLumiraDxDomestic: AR, CA, FL, MA, MD, NC, NJ, NV, NY, OK, TN, TX, & WI.Official notice →